long covid

Dr. M’s SPA Newsletter Audiocast Volume 13 Issue 9

Coronavirus Update 81 plus other stuff
We continue to have a highly infectious Omicron endemic national state with new strain XBB.1.5 accounting for 75% of our cases now with absolutely no signs of worsening disease severity or morbidity. Having had a previous Omicron natural infection is beneficial towards preventing moderate to severe disease from current circulating Omicron strains, but not helping against getting mild infection at all. This week we look at the residual data that is of interest. It is thinning out for me. We also look at men’s health and the micronutrient iodine.
Enjoy,
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 13 Issue 5

 

Covid update #79 – This week we do a literature review looking at Covid and the post illness effects on lipid metabolism, chemical clearance and general long term health. We look at the effects of different mask types. We have a lifestyle Covid illness mitigation strategy moving forward. We finish with a look at liver and a recipe using liver as a main ingredient.   Enjoy, Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 51

Coronavirus Update 76 plus other stuff
The work around Covid research is fading for me. This is now mostly a highly contagious upper respiratory infection for most. The morbidity has faded to a level where we are seeing very limited disease in children and the hospital data remains completely plateaued. Unless there is a dramatic shift in this virus, we are moving toward a world where Covid will be like the other 4 circulating coronaviruses for most of the United States population save for the high risk individuals as described throughout the pandemic.
Focus remains on self care to boost all immune activity to thwart all infections from all microbes.
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 49

Covid Update #75

All new omicron based variants are extremely infectious but not really dangerous anymore to immunocompetent people. They are evading prior immunity as well as all vaccines to varying degrees. Morbidity remains very low now. The current bivalent vaccines are not showing any improvement over the ancestral vaccine. Death remains almost zero for all healthy previous infected or vaccinated individuals. This is likely the new norm from here on out.

This week we cover covid, vaccine effectiveness, skeletal muscle and dementia, human protein needs and function.

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 45

Covid Update # 73:
Omicron US strains: as of October 22nd data – variants make up: BA.4.6 is 11%, BA.2.75 is 2%, BF.7 is 7%, BA.5 is 62%, BQ.1 is 9%, BQ1.1 is 7%
BA.5 is losing ground to many new Omicron variant offshoots. BF.7, BQ.1 and BQ1.1 are very interesting as they are apparently more infectious than BA.5. That is amazing.
We look at new PASC Long Covid data as well as the world of vaccine effectiveness. And much more…
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 41

Coronavirus Update #71 A look at the next pandemic

From a recent article, we see a 10 point series of mitigation measures for a future pandemic based on rational thought: “A more realistic public health approach is to adjust current mitigation goals to be more data-driven and to minimize unintended harms associated with unfocused or ineffective control efforts.”
a) Accelerate vaccinations, b) ease restrictions as fast as possible based on science, c) emphasize education and harm reduction, d) Encourage outdoor activity, e) reopen schools, f) avoid lockdowns, g) deemphasize ineffective mitigation measures, h) reassess testing, i) expand treatment and prophylaxis, j) prepare for future pandemics.
And more…
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 39

Coronavirus Update #70 GOOD NEWS: This information is so important to help us all understand risk. Stratified risk is the only true way to measure personal risk. Let us look at some CDC data from the spring Omicron BA.1 and .2 spikes versus the fall 2021 delta wave.
Median age of hospitalization has increased from 60 years old with Delta to 64 with BA.1 and 71 with BA.2. Any underlying medical condition associated with hospitalization increased from 89% with Delta to 92% with BA.1 to 95% with BA.2 respectively. Length of hospital stay decreased from 4.8 to 3.9 to 3.3 days. ICU admission was down from 24% to 18% to 13% of admitted patients. Mechanical ventilation decreased from 14% to 8% to 6% of admitted patients. And Finally, death from 12% to 8% to 5% overall.

What we can glean from this data set is very clear. With successive SARS2 mutations coupled to increased population based exposure to virus via infection or vaccine, we are now seriously in a reduced risk state unless you are older than 65 years with a comorbid disease or younger than 65 with a serious disease. 95% of hospitalizations were related to a comorbid disease regardless of age. The other big takeaway was this: if you are in this high risk group, getting every available booster is vital to your survival based on the risk reduction data. For everybody else, the data is clear, you are ok – to boost or not to boost is up to you. But, absolutely work on your general health.

To your health,
Dr. M